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INTRODUCTION
Primary care opioid prescribing1–4 to 
treat chronic non-cancer pain (CNCP)5– 11 
has progressively increased over the last 
20 years.5–14 Prescribing varies geographically 
with larger practice list size, rural, and 
higher deprivation areas associated with 
high-dose opioid prescribing,14 despite a 
lack of evidence for their long-term safety 
and effectiveness.1,15,16 A small proportion of 
people may experience effective pain relief 
from CNCP through opioid use if the dose 
can be kept low and daily use avoided.17,18 
However, many patients stop using opioids 
long term because of adverse events or 
inadequate pain relief.1 CNCP, defined as 
any painful condition lasting for >3 months 
not associated with a diagnosis of cancer, is 
estimated to affect 35.0% to 51.3% of adults 
in the UK.19 In the UK and internationally 
there is growing awareness of prescription 
opioid-related harms.13,20–27 Long-term use 
of prescription opioids in CNCP is associated 
with several adverse events28 including 
opioid analgesic dependence (OAD), 
addiction, and opioid-related death.2,29–35 For 
example, in 2017 there were 156 codeine- 
and 185 tramadol-related deaths recorded 
in England and Wales.35 Variable prevalence 
rates of prescription opioid dependence 
have been reported.36–39 People dependent 
on prescription opioids are less likely to 
access traditional specialist substance 
misuse services than those dependent on 
illicit opioids,40 as they may not perceive 
themselves to be dependent,41 may be 
concerned about being labelled an ‘addict’ 
and the stigma associated with methadone 
use,42 and may not want to access the same 
services as ‘addicts’.43 It is recommended 
that commissioners seek to provide 
separate services to treat prescription opioid 
dependence44 with strong collaboration 
between drug services and the patient’s GP.45 
There is currently no evidence for the efficacy 
or safety of interventions designed to reduce 
prescribed opioid use for CNCP.46 Therefore, 
developing primary care-based interventions 
to reduce opioid dependence in patients with 
CNCP is a public health priority. 
The aim of this research is to report the 
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Abstract
Background
Primary care opioid prescribing to treat chronic 
non-cancer pain (CNCP) has progressively 
increased despite a lack of evidence for long-
term safety and effectiveness. Developing 
primary care interventions to reduce opioid 
dependence in patients with CNCP is a public 
health priority. 
Aim
To report the acceptability of the South 
Gloucestershire pain and opioid review service 
for patients with CNCP, which aimed to help 
patients understand their relationship with 
prescribed opioids and support non-drug-
based pain management strategies. 
Design and setting
A mixed-methods evaluation was performed 
on the service, which was based in two GP 
practices in South Gloucestershire, England, 
and delivered by project workers. 
Method
Descriptive data were collected on delivered-
within-service and community-based 
interventions. Twenty-five semi-structured 
interviews (n = 18 patients, n = 7 service 
providers) explored experiences of the service.
Results
The enrolment process, person-centred 
primary care-based delivery, and service 
content focused on psychological issues 
underlying CNCP were found to be acceptable 
to patients and service providers. Patients 
welcomed having time to discuss their pain, its 
management, and related psychological issues. 
Maintaining a long-term approach was desired 
as CNCP is a complex issue that takes time to 
address. GPs recommended that funding was 
needed to ensure they have dedicated time to 
support a similar service and to ensure that 
project workers received adequate clinical 
supervision.
Conclusion
This service model was acceptable and may be 
a useful means to manage patients with CNCP 
who develop opioid dependence after long-
term use of opioids. A randomised controlled 
trial is needed to formally test the effectiveness 
of the service. 
Keywords
chronic pain; health promotion; opioid-related 
disorders; pain; pain management; primary 
health care.
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acceptability, defined as the perceived 
appropriateness of an intervention.47 An 
evaluation of the service’s potential impact 
on participants’ health and wellbeing is 
presented elsewhere.48 
Pain and opioid use service 
The South Gloucestershire Council Public 
Health and Wellbeing Division commissioned 
the service for 2 years from September 2016. 
It was delivered in two GP practices that 
were selected for the presence of clinician 
expertise or interest in substance misuse. 
The providers were Developing Health and 
Independence (DHI), which offers services, 
including drug and alcohol treatment, to 
support disadvantaged and marginalised 
people,49 and Battle Against Tranquillisers 
(BAT), a service designed to reduce the harm 
caused by benzodiazepines, tranquillisers, 
and sleeping pills.50 The latter provider 
subsequently withdrew owing to a lack 
of patients with co-occurring opioid and 
benzodiazepine dependence. 
Adult patients prescribed opioids for CNCP 
for >3 months (defined as long term)2 and 
receiving at least three prescriptions in that 
period were eligible to receive the service. 
Though the definition of ‘long term’ varies 
in the published literature,28 the researchers 
used >3 months as this time period has been 
used in the literature and reflects the lack 
of evidence for the long-term effectiveness 
of opioids for CNCP.1,11,17,28,51 Patients using 
illicit drugs only or receiving end-of-life care 
were ineligible. An opioid risk assessment 
tool (ORAT) was used to screen medical 
records and identify cohorts of potentially 
eligible patients. Project workers sent 
eligible patients invitation letters on behalf of 
the GP practice.
The service was informed by the shared-
care model, which is a partnership approach 
to care between specialists and GPs for those 
with drug misuse issues. The shared-care 
model is common in the delivery of treatment 
for illicit drug addiction.42 It includes the 
prescription of opioid substitution therapy 
(OST), used to reduce the use of illicit drugs, 
and psychosocial interventions. It has been 
shown to be effective in reducing mortality 
rates52 and blood-borne virus transmission53 
in this population. The evidence base for 
the treatment of dependence on prescribed 
opioids is weak and draws on the evidence 
for the treatment of heroin dependence.42 
For example, it is currently unknown 
whether people dependent on prescribed 
opioids respond to OST in the same way as 
those dependent on heroin.42 Furthermore, it 
is important to note that not all patients with 
CNCP on high doses of opioids will meet 
the definition of dependence; therefore, 
these individuals would not benefit from 
treatment such as OST. The service was also 
underpinned by patient-centred counselling 
and cognitive behavioural therapy principles, 
and aimed to promote partnership working 
between two project workers, GPs, and 
consultants in pain management and 
addiction psychiatry. Patient review 
meetings between service providers were 
planned approximately monthly.
Once enrolled, an assessment was used 
to co-produce a tailored pain management 
plan with patients involving non-medical 
pain management strategies, including 
pacing (breaking tasks into manageable 
units), encouragement of movement and 
strength-building exercises, following a 
pain management book,54 mindfulness 
How this fits in
Primary care opioid prescribing to treat 
chronic non-cancer pain (CNCP) has 
progressively increased despite a lack 
of evidence for long-term safety and 
effectiveness. This mixed-methods 
study reports the acceptability of a new, 
primary care-based service, the South 
Gloucestershire pain review service, aimed 
at helping patients with CNCP on long-
term opioid painkillers to explore their use 
of opioids, support non-pharmacological 
pain management strategies, and reduce 
their opioid dosage. This study found that 
the service was acceptable to service users 
and providers. The findings can be used to 
inform future service design highlighting 
the importance of the project worker and 
the value of running a flexible, individually 
tailored service. 
Awareness and
understanding
of pain
Recruitment
Identify and
enrol eligible
patients from
GP practice
Assessment
of service
user needs
Pain management
plan co-created
with service users
Within-session
components:
•Goal setting
•Education
•Counselling
•Medication
 review
•Pain management
 strategies
Opioid use, pain
levels, and
management
Wellbeing, mental
health, and quality
of life
Healthcare use
and delivery
Intervention content
Referral to
external services:
•Physiotherapy
•Relaxation and
 mindfulness 
 group
Outcomesa
Figure 1. Intervention logic model. 
aPresented elsewhere.
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and relaxation exercises, and goal setting 
(Figure 1). These strategies were provided 
either by project workers within sessions or 
through community-based services, akin to 
social prescribing.55 The sessions involved 
evidence-informed discussions supported 
by written and video resources on how 
pain and opioids work, and how changing 
thinking styles and improving mental health 
can improve pain symptoms. This education 
aimed to enable patients to understand their 
pain and assess whether their opioids were 
working. The service involved reviewing the 
opioid type and dose, and, as appropriate, 
discussing and supporting a reduction in 
opioids (de-scripting). 
METHOD
A mixed-methods evaluation was performed 
between August 2017 and August 2018. 
Descriptive data
This article presents data from 25 semi-
structured interviews (18 patients, 7 service 
providers) describing within-service and 
community interventions collected by 
project workers. 
Qualitative data
A convenience sample from those patients 
who gave permission to be contacted were 
invited by telephone to take part in a one-
to-one semi-structured interview either in 
person or by telephone. This was followed 
up by a patient information sheet further 
explaining the study. Interview participants 
provided written or audio-recorded verbal 
informed consent. Patients received GBP 10 
shopping vouchers to thank them for their 
time.
Patient interview topic guides explored 
experiences of the service, including what 
worked well and what could be improved. 
Patient age, sex, previous pain clinic use, 
and pain medication were recorded. 
Interviews with service providers (lead 
GPs, any GPs involved in the service, the 
project workers, and the service delivery 
manager) explored views on the service 
and partnership working. GP practices 
were reimbursed GBP 40 per 30-minute 
interview for the GPs’ time. 
The interviews captured several 
acceptability constructs:47 ‘affective attitude’ 
(feelings towards the service); ‘burden’ 
(effort required to participate); ‘intervention 
coherence’ (understanding of the 
intervention and how it works); ‘perceived 
effectiveness’ (extent to which intervention 
is perceived to achieve its goal); and ‘self-
efficacy’ to perform intervention behaviours.
Data collection ended when enough 
information to explore perceptions of the 
service had been obtained. This decision was 
informed by the ‘information power’ concept, 
meaning, the greater the information 
provided by participants, the smaller the 
sample required.56 Issues informing 
information power include: the breadth of 
the study aim, that is, broader aims require a 
larger sample as the phenomenon covered 
is more comprehensive; characteristics 
of the participants, that is, a sample with 
rich experiences relevant to the research 
can be smaller than one with less relevant 
experiences; depth and quality of data, that 
is, focused and clear data require a smaller 
sample; and the analysis approach, in other 
words, an exploratory analysis requires 
a larger sample than a more focused 
approach.56
Analysis
Qualitative analysis began shortly after data 
collection and informed changes to the topic 
guides. Inductive thematic analysis57 was 
performed using QSR NVivo (version 10).58
RESULTS
Of 34 patients, 22 (65%) consented to be 
contacted about an interview. Two declined 
to be contacted (one had ‘too many things 
to cope with’ and one was ‘too ill’) and 
one was not invited because of mental 
health problems. Nine were not asked 
for permission to be contacted as data 
collection had finished. Two patients who 
agreed to be contacted were not invited 
as adequate data had been collected to 
understand experiences of the service.56 In 
total, 20 patients were invited to participate, 
of whom 18 agreed and two did not respond, 
giving a 90% recruitment rate. Participant 
characteristics are presented in Table 1 
and details of the entire cohort are available 
from the authors on request. 
Seven service providers (n = 2 project 
workers, n = 1 service delivery manager, 
n = 4 GPs) were interviewed. An addiction 
specialist and consultant psychiatrist did 
not respond to interview invitations. 
Experiences of the new service
Enrolment into the service. The ORAT tool 
was found difficult to use and insensitive, 
generating large numbers of records for 
the project workers to screen and discuss 
with GPs. Instead, GPs’ direct referrals were 
regarded as more efficient. 
The invitation process was acceptable to 
most patients as referral was experienced 
as informal, quick, and easy. Most patients 
described receiving clear invitations 
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from GPs during consultations and via 
letters. GP endorsement enhanced the 
perceived trustworthiness of the service 
and encouraged participation. In contrast, 
one patient negatively experienced a verbal 
invitation from their GP as the GP implied 
the intention was to stop their opioid 
prescription. Another reacted negatively to 
the mention of the organisation, BAT, in the 
invitation materials: 
‘It [invitation letter] said it was called BAT, 
Battling Against Tranquillisers … that did sort 
of really upset me because I think battling 
against tranquillisers is someone who’s using 
them as an addictive thing and I wasn’t using 
them because I was addicted. I was using 
them to combat pain so I could continue a 
semi-normal life. … The doctors have been 
readily giving out these prescriptions, so if 
anyone’s battling against tranquillisers it’s 
the doctors.‘ (Patient [P], interview [I] 21)
Assessment process and pain management 
plan development. Project workers 
described the assessment process 
as building a relationship with patients, 
enabling them to understand their lives 
and identify issues affecting them and their 
pain. Most patients found the assessment 
process acceptable:
‘Straight from the off he [project worker] is 
not sort of judging you if you know what I 
mean? He’s sort of understanding what’s 
going on and … some of the things he said 
then made sense to me.’ (P, I8)
Within-session components. Project 
workers used a range of strategies including 
encouraging pacing, physical exercises, 
following a pain management book, 
mindfulness and relaxation exercises, and 
goal setting. The proportion of all patients 
(not only those interviewed) receiving each 
within-session intervention (Figure 2) was 
as follows: pain management book (74%), 
OAD worksheets (71%), de-scripting (62%), 
exercise planning (53%), and sleep hygiene 
(50%).
Pain management strategies
Patients learnt about pacing and strategies 
for avoiding the ‘over-activity trap’: the 
perceived need to complete many tasks 
on ‘good pain days’ that contribute to 
subsequent ‘bad pain days’: 
‘First of all, it was just sort of talking and 
then it was coping strategies, pacing — I’m 
not good at pacing — if I have a good day … 
I try and get everything done and am then 
knocked out for a couple of days but now 
I’ve learnt to I’ll perhaps iron a couple of 
things and then I’ll sit down rather than 
stand there and do the whole lot.‘ (P, I1)
Several patients described the pain 
management book and accompanying 
relaxation CD as helpful, informative, and 
relatable. A small number described using 
the book to help formulate goals as well 
as using it outside of sessions. However, 
others described difficulties concentrating 
Table 1. Interview participant characteristics, N = 18
  Interviewed service  
Characteristics  users n (%)a
Female 12 (66.7)
Mean age, years (SD) 52.8 (9.8)
Employment status
 Unemployed/retired 15 (83.3)
 Employed 3 (16.7)
Living with anyone
 Yes 12 (66.7)
 No 6 (33.3)
GP practice
 Practice 1 9 (50.0)
 Practice 2 9 (50.0)
Mental health issues (diagnosed or undiagnosed)
 Yes 11 (61.1)
 Depression 10 (—)
 Anxiety 2 (—)
 Bipolar tendencies 1 (—)
 No  7 (38.9)
Previous attendance at pain clinic 
 Yes 15 (83.3)
 No  3 (16.7)
Description of painb
 Arthritis/osteoarthritis  9 (50.0)
 Generalised and localised joint and muscular pain  9 (50.0)
 Crohn’s disease 1 (5.6)
Opioid drugb
 Buprenorphine 4 (22.2)
 Codeine family 11 (61.1)
 Morphine 9 (50.0)
 Oxycodone family 7 (38.9)
 Tramadol 4 (22.2)
Baseline medication (excluding opioids)b
 Benzodiazepines 5 (27.8)
 SSRI antidepressants 1 (5.6)
 Other antidepressants 1 (5.6)
 Amitriptyline 3 (16.7)
 Gabapentin 3 (16.7)
 Pregabalin 1 (5.6)
 Other 18 (100.0)
aUnless described otherwise. bPatients taking more than one class of opioid or baseline medication contribute 
a count to each class of drug they take, therefore percentages do not add up to 100%. SD = standard deviation. 
SSRI = selective serotonin reuptake inhibitors.
British Journal of General Practice, Online First 2019  4
on the book, and some parts were said to be 
irrelevant and to oversimplify CNCP:
‘… and the little books were brilliant 
because you do feel that you’re on your 
own, that nobody else sort of understands, 
and my husband’s read it, and … you think, 
“Oh yeah, that’s me, that’s me”, so yeah, it 
was really interesting.’ (P, I12)
‘I got sort of irritated by [the book] and … I 
tried my best to sort of have an open mind 
with it but I just really didn’t like it. It’s very 
rigid as well and you know, well I found it 
rigid.’ (P, I9)
Opioid review and changes. Some patients 
were keen to conduct a review of their 
medication and to reduce their dose or 
change the type of opioid, driven by a 
recognition that they were on a high dose, or 
wanted to reduce the side effects from their 
medication. Overall, GPs facilitating changes 
to prescriptions worked smoothly, though 
time delays were experienced by some. A 
small number of patients had reservations 
about reducing their dose at home, rather 
than as a hospital in-patient, because of 
fears about withdrawal symptoms:
‘We would talk for quite a long time about 
the withdrawal and in the beginning, I was 
really scared and I said “Well, there’s no 
way I am doing it unless you can send me to 
somewhere where I can actually live in and 
sort of you know?“ But, we sort of discussed 
that and then I sort of thought “Well, no, I 
think I can do it with his help and support.”’ 
(P, I9) 
Community-based services. The 
highest proportion of patients selected 
physiotherapy services and participation 
in a relaxation group (53% respectively) 
(Figure 3). Other community-based social 
prescribing services focused on: quality 
of life; social interaction and self-esteem 
through voluntary work; applying for an 
assistance dog; a ‘Men in Sheds’ project 
(community spaces for men to connect 
to help reduce loneliness and isolation); 
physical activity, for example, gym sessions; 
and financial advice and support, for 
example, personal independence payment 
claim support and working rights advice: 
‘He really helped me with that [applying for 
an assistance dog] because again, with my 
confidence I was reluctant to sort of ring 
them up … and he was like “No, you do it” 
and I did.‘ (P, I9)
Three patients talked about appreciating 
funding to access community services. 
A small number of patients and project 
workers described delays accessing some 
services, owing to long waiting lists. 
The project workers and some patients 
described enjoying the relaxation group, 
finding it helpful and valuing connecting 
with others in a similar situation. Group 
attendance was variable, and two patients 
Figure 3. Proportion of patients accessing community-
based services and social prescribing. 
OAD = opioid analgesic dependence.
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5  British Journal of General Practice, Online First 2019
were unable to attend because the group 
ran during the working day. A small number 
of patients were intimidated by the group 
format and did not feel confident to attend:
‘At first, I hated the breathing … I think a 
lot of that was to do with my confidence 
as well because I felt very self-conscious 
in the group, breathing with other people, 
and I think a few people probably felt it but I 
vocalised it and they were all really supportive 
… but when I came home, obviously what I 
learnt there, I was able to practise here and I 
felt more comfortable.‘ (P, I9)
Service approach
Patient-centred counselling. Session day, 
time, frequency, content, pace, and location 
were selected and modified to suit patient 
needs. Service duration was also more 
open ended than previous services, running 
for a maximum of 2 years. Patients liked 
this approach because it was more person 
centred than other services and reduced 
the pressure on them to make lifestyle 
or medication dose changes within a set 
timeframe. A few patients talked about their 
partners, parents, or carers attending some 
or all sessions that offered them insights into 
what the patient was experiencing, enabling 
them to support the patients, and helped the 
patient recall what had been discussed. 
Patients appreciated that the service 
was not like the traditional medical model 
or mental health and pain management 
services. All interviewee groups reported 
that patients valued having time to discuss 
their pain and its management with 
someone who could spend time listening to 
them. Patients and providers acknowledged 
that GPs do not have time to discuss pain 
management or reduction in medication in 
detail, owing to limited appointment times: 
‘It was one-on-one as well and it wasn’t 
rushed. If you had something to say he would 
just sit there or advise or listen.‘ (P, I21) 
Relationships and communication. Project 
workers and GPs described the importance 
of forming a trusting relationship with 
patients in supporting openness during the 
sessions, and willingness to try suggested 
strategies. Patients described the project 
workers as encouraging, motivating, kind, 
and good listeners. They provided advice 
and supported them to implement changes 
related to pain management in a gentle 
way. The continuity of the project worker 
was experienced positively. Communicating 
confidentially with someone who was non-
judgemental, understood the physiology 
and psychology of pain, empathised with 
their experience, and was outside of the 
immediate family or caring network was 
welcomed: 
‘I’m enjoying the fact that I’ve got somebody 
outside of my immediate family that I can 
just chat to that understands what I’m 
going through and can sort of guide me, 
you know, as to how to move forward and try 
and avoid painful flare-ups.‘ (P, I14)
Project workers consulted with GPs about 
opioid reductions and changes to patient 
medication, and kept GPs updated about the 
sessions through written notes on patient 
records and an internal messaging system. 
Most GPs felt this method of communication 
worked well, and project worker liaison with 
GPs was viewed positively by most patients. 
Project workers who were based in the GP 
practice facilitated informal conversations 
with GPs. Two patients commented on the 
sense of safety and reassurance that GP 
involvement provided for them: 
‘Within EMIS [patient administration 
system] you can send tasks to users and so 
he [project worker] can send a task about a 
specific patient, saying I’ve seen him today. 
Certainly, when he starts dose reduction, 
he’ll tell you what he’s doing, and he’ll put 
the plan on the record. It’s helpful to have a 
summary of what he’s doing with people.‘ 
(GP, I20)
A small number of patients experienced 
communication problems with the GP or 
project worker. For example, one patient 
was refused appointments with their GP 
as they were under the care of the project 
worker. Instead, the GP and project worker 
discussed the patient’s care without them. 
This patient disliked not being present for 
these conversations and having access 
to the GP restricted. Other patients also 
wanted more support from the GP during 
the service, especially when reducing 
opioids, for example, one patient felt more 
clinical expertise and general support from 
a GP was needed: 
‘I think it is important if you’re reducing that 
you are, I mean not to get special treatment, 
but you are able to have access to a doctor, 
even if it’s just a phone call to say, you know, 
can you help me.‘ (P, I9)
One GP described supporting patients 
when they were reducing their opioids 
through phone calls and house visits. The 
lead GPs described struggling to allocate 
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time to support the project workers as 
their time was unfunded. A lack of clinical 
supervision left the project workers feeling 
inadequately supported at times. 
Scheduling multidisciplinary meetings 
between GPs, project workers, and 
addiction or pain specialists was difficult, 
and the involvement of the psychiatrist 
and pain specialist consultant was less 
than anticipated. The project workers were 
disappointed by this and felt that delayed 
responses from specialists negatively 
affected the patients’ confidence in their 
knowledge and ability to support them.
Focus on wellbeing and mental health. All 
participant groups described the service 
as supportive of improvements in patient 
wellbeing and providing support for 
complex social and psychological issues, 
including social isolation, bereavement, 
problems related to family life, finances 
and employment, histories of trauma and 
abuse, low self-esteem and confidence, 
anxiety, and depression. Such issues had 
become intrinsically linked to CNCP either 
as a cause, contributor, or consequence. 
Project workers described trying to 
address patients’ negative self-image by 
encouraging self-kindness. 
Project workers observed that opioids 
were used by some people for reasons 
other than pain management, such as 
sedation and management of psychological 
symptoms:
‘For some people if you track over a week 
how they’re taking it, then you can kind of 
see patterns that don’t correspond with pain 
spikes. So, people are using it for something 
else and there’ve been a couple of “aha” 
moments with clients where they’ve gone 
“oh right, yes it goes up when my horrible 
father comes and gives me [hell]” and 
someone going “yes, I sedate myself”.’ 
(Project worker 1, I13)
A self-assessment worksheet helped 
patients identify patterns of opioid use 
coinciding with stressful periods rather than 
pain spikes, thus increasing self-awareness 
of the link between wellbeing and pain. 
A negative unintended consequence of 
discussing the relationship between the 
mind and pain was for a small number of 
patients to think the project worker was 
implying their pain was not ‘real’: 
‘In the research [there is a] huge overlap 
between kind of your emotional state 
and the amount of pain you feel. Also, 
around your ability to kind of tolerate the 
frustrations of pain. If you’re not in a good 
space, you’re not gonna be able to do that. 
If you’re not in a good space, the chances 
are you’re gonna be at home. If you’re at 
home you’re not working, you’re not going 
to feel good about yourself. If you’re not kind 
of working your body’s gonna start moving 
less so there’s this … horrible … downward 
spiral.‘ (Project worker 1, I13)
Two patients thought the pace of moving 
onto certain aspects, such as looking at their 
hobbies or starting to consider reducing 
their medication, would be discussed earlier 
on, but they acknowledged the need to 
address other mental health-related issues 
first to ensure they were ready. Indeed, 
setting goals was described by a small 
number of patients and Project worker 2 
as challenging because of psychological 
readiness, emotional state, and general 
struggle to commit to setting goals. 
For example, confronting troubling issues 
including past trauma was difficult for some: 
‘In the early days I did find it quite difficult 
because when you’re talking about your 
pain and your lifestyle, it’s just highlighting 
how bad you feel.‘ (P, I2)
Factors to consider for service 
development
Most GPs and patients made no critical 
comments about the service and nine 
patients wanted the service to be kept 
the same in future. Keeping the service 
person centred and not prescriptive was 
viewed as important. Maintaining a long-
term approach was desired by patients and 
project workers as CNCP is a complex issue 
that takes time to address, and requires a 
trusting relationship with the project worker. 
There was agreement among the GPs 
and project workers that identifying eligible 
patients using clinician knowledge rather 
than software should continue. To enhance 
its effectiveness, two GPs proposed that 
the service could target patients who have 
expressed concern about their opioid 
use and motivation to change. GPs also 
commented that this type of service could 
be used to support patients from the onset 
of a pain condition to prevent long-term 
opioid use. Indeed, two patients talked 
about being unaware of their medication’s 
addictive properties when first prescribed.
The project worker–patient relationship 
was perceived to be crucial for ensuring 
the success of any future service. However, 
the importance of commissioning a service 
rather than employing individual project 
workers was recognised. Both project 
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workers warned against running the service 
with high numbers of patients and short 
appointment times, as this would undermine 
the ability to form a therapeutic relationship.
GPs highlighted the need for funding 
to support their involvement in future. 
Similarly, continuing a budget for each 
patient was recommended. 
All participant groups agreed that 
running the service within GP practices 
was important in terms of access, 
communication, and familiarity. 
Additionally, one project worker felt the 
service could be embedded within the pain 
management pathway offering services 
within the community either before or after 
engagement with pain management clinics. 
DISCUSSION
Summary
The enrolment process, open-ended, 
person-centred, primary care-based delivery 
and content focusing on psychological 
issues underlying CNCP, were acceptable 
elements of the South Gloucestershire pain 
review service. Patients welcomed having 
time to discuss their pain, its management, 
and related psychological issues with a 
consistent and supportive project worker. 
The service has also been found to be feasible 
in relation to recruitment, attendance, and 
ability to measure outcomes.48
Strengths and limitations
Interviews were conducted with a diverse 
range of patients and providers, allowing 
triangulation of experiences and enhancing 
the findings’ credibility. Using qualitative 
methods facilitated an in-depth exploration 
of the acceptability of the service.59,60
The patients’ close relationship with 
the project workers may have resulted in 
reluctance to provide critical comments. 
However, the findings reflect a range of 
positive and negative views, suggesting the 
risk of this was minimal.
The GP practices were selected for the 
presence of clinician expertise in substance 
misuse. Therefore, it is unclear whether the 
service would be acceptable or successful 
elsewhere. 
Comparison with existing literature
There is a dearth of evidence, including trials, 
on the efficacy or safety of interventions 
designed to reduce dependence on 
opioids prescribed for CNCP.46 Public 
Health England are currently reviewing 
the evidence for effective prevention and 
treatment of dependence, and withdrawal 
and discontinuation syndrome for 
prescribed medicines (including opioid pain 
medications).61 A self-management group 
intervention (COPERS) to help people cope 
with chronic musculoskeletal pain delivered 
over 3 days by trained facilitators, and an 
additional session after 2 weeks, was not 
effective in reducing pain-related disability at 
12 months, though benefits were observed 
at 12 months for depression and social 
integration.62 The findings from the current 
service suggest that prolonged engagement 
helps enhance service acceptability, which 
in turn could support improved outcomes. 
The I-WOTCH (Improving the Wellbeing of 
People with Opioid Treated Chronic Pain) 
trial is currently examining the effectiveness 
of the COPERS intervention combined 
with individual support for people using 
strong opioids for CNCP.63 The presented 
study highlights the importance of such 
individually tailored support.
The need to address this problem using 
a multidisciplinary, personalised approach, 
focused on alternative pain management 
strategies and addressing psychological 
issues underlying pain, is recognised.40,64–66 
This pilot study is similar to other social 
prescribing initiatives highlighting benefits 
and challenges of collaborative working and 
issues of insufficient capacity and funding.67 
Primary care is believed to be an ideal 
place for managing patients with prescription 
opioid dependence.65,68 Furthermore, GPs are 
generally supportive of the recommendation 
to provide separate services for the 
treatment of prescription opioid dependence, 
and recognise that they have an important 
role to play in identifying and treating these 
patients.38 Efforts to improve prescribing 
appropriateness have been called for.14 A GP 
training component was originally planned 
as part of the service. However, due to a lack 
of appropriate expertise, this component 
could not be delivered, and therefore the 
acceptability and perceived value of this is an 
area for further research.
Implications for research and practice
This service model may be a useful means 
to manage patients with CNCP using 
prescribed opioids long term. The findings 
can be used to inform future service design, 
highlighting the importance of the project 
worker and the value of running a flexible, 
individually tailored service incorporating 
social prescribing. In the future, funding 
would be needed to ensure GPs have 
dedicated time to support a similar service, 
and to ensure that project workers receive 
adequate clinical supervision. A randomised 
controlled trial and economic evaluation are 
needed to formally test the effectiveness of 
the service.
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